Cart
sales@molnova.com
3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
CAS No. ———
3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid( ——— )
Catalog No. M38487 CAS No. ———
3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
-
NoteResearch use only, not for human use.
-
Brief Description3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
-
Description3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ropivacaine HCl mono...
Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.
-
Lirilumab
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition.
-
Ganoderic acid M
Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low.
